Gevo Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits

$GEVO
Major Chemicals
Industrials
Get the next $GEVO alert in real time by email
false 0001392380 0001392380 2025-01-31 2025-01-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 31, 2025

 

 

Gevo, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware 001-35073 87-0747704
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation)   Identification No.)

 

345 Inverness Drive South, Building C, Suite 310
Englewood
, CO 80112

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (303) 858-8358

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol   Name of exchange on which registered
Common Stock, par value $0.01 per share   GEVO   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On January 31, 2025 (the “Closing Date”), Gevo, Inc., a Delaware corporation (the “Company”), closed its previously announced transaction pursuant to that certain Asset Purchase Agreement (the “Purchase Agreement”) by and among the Company and its wholly owned subsidiaries Richardton CCS, LLC, a Delaware limited liability company (“R-CCS”), and Net-Zero Richardton, LLC, a Delaware limited liability company (“NZ-R”, and together with R-CCS, the “Buyers”), and Red Trail Energy, LLC, a North Dakota limited liability company (“Seller”). Pursuant to the Purchase Agreement, and subject to the terms and conditions thereof, the Buyers acquired substantially all of the assets, and assumed certain liabilities, of Seller on the terms set forth therein (the “Transaction”).

 

Credit Agreement

 

On the Closing Date, Net-Zero North HoldCo, LLC, a Delaware limited liability company (the “Borrower”), R-CCS, NZ-R (R-CCS, NZ-R and Borrower collectively , the “Project Companies”), Gevo North Dakota Operations, LLC, a Delaware limited liability company (“Operations Company”), and Gevo Intermediate HoldCo, LLC, a Delaware limited liability company (“Holdings”, and together with the Project Companies and the Operations Company, the “Guarantors”), each a direct or indirect subsidiary of the Company, entered into a Credit Agreement (the “Credit Agreement”) with OIC Investment Agent, LLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”) and as collateral agent for the Secured Parties (in such capacity, the “Collateral Agent”), and the lenders from time to time thereto (“Lenders”).

 

The Credit Agreement provides for a $105 million senior secured term loan that was funded on the Closing Date (the “Term Loan”) with a maturity of January 31, 2030. The proceeds of the Term Loan were used to partially fund the previously announced Transaction and the payment of fees under the Credit Agreement. The Credit Agreement also provides for additional uncommitted term loans in an aggregate amount to be mutually agreed upon by the Borrower, the Guarantors and the Lenders for use for certain future growth opportunities after the Closing Date. Interest on the Term Loan will accrue at a rate of (i) 10.00% per annum if the net leverage ratio as of the last day of the quarter for the measurement period (the “Measurement Period”) consisting of the prior four consecutive fiscal quarters of the Borrower (“Leverage Ratio”) is less than 1.5x, (ii) 10.75% per annum if the Leverage Ratio is equal to or greater than 1.5x, but less than 3.0x, and (iii) 11.50% per annum if the Leverage Ratio is equal to or greater than 3.0x and shall initially be set at 11.50% per annum until the next quarterly adjustment date. The Leverage Ratio is defined as the ratio of the combined indebtedness of the Borrower and the Guarantors (other than any indebtedness pursuant to any permitted working capital facility) less any cash equivalent investments in any collateral accounts to the consolidated EBITDA of the Borrower and Guarantors for the relevant Measurement Period. Interest will be due and payable in cash at the end of each quarter.

 

In connection with the Term Loan, and subject to the other terms under the Credit Agreement, Lenders made an equity investment in Holdings equal to $5 million on the Closing Date. The organizational documents of Holdings also provide Lenders with the right to appoint two non-voting observers to the board of managers of Holdings. Other than the transactions described herein, the Lenders and the Collateral Agent do not have any material relationship with the Company or its affiliates.

 

The Term Loan is secured by a first-lien security interest subject only to reasonable and customary permitted liens and encumbrances, in all the Borrower’s and each Guarantor’s tangible and intangible assets, properties controlled by Borrower and Guarantors, and contracts, including deposit accounts and collateral assignment of material contracts and certain real estate assets to be determined, and includes a pledge of all equity interests in the Borrower and its subsidiaries. The Credit Agreement also contains customary affirmative and negative covenants, events of default, mandatory prepayments (including an excess cash flow sweep), conditions precedent, representations, and warranties.

 

The foregoing descriptions of the Credit Agreement and the Term Loan do not purport to be complete and are subject to, and qualified in their entirety by, the full texts of the Credit Agreement and Form of Term Loan Note, copies of which are filed herewith as Exhibits 10.1 and 10.2, and are incorporated herein by reference.

 

 

 

 

Item 2.01. Completion of Acquisition or Disposition of Assets.

 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

 

The aggregate purchase price was $210 million, subject to customary adjustments, including a working capital adjustment (the “Purchase Price”). The Purchase Price was funded by a mixture of Company cash on hand and $105 million of debt financing from the Term Loan.

 

As previously disclosed, the Company and Seller entered into an escrow agreement pursuant to which the Company had deposited $10 million in earnest money, which was applied against the Purchase Price. In addition, pursuant to such escrow agreement, the Company deposited on the Closing Date (i) $1.26 million of the Purchase Price for the purposes of securing the post-closing indemnification obligations of Seller, and (ii) $5 million of the Purchase Price for purposes of securing any Purchase Price adjustments. Buyers obtained a representation and warranty insurance policy to provide coverage for certain breaches of representations and warranties of the Sellers, which coverage is subject to certain exclusions, deductibles and other terms and conditions as set forth in the policy.

 

The material terms of the Purchase Agreement were previously reported in Item 1.01 of the Current Report on Form 8-K filed on September 12, 2024 (the “September Form 8-K”) with the U.S. Securities and Exchange Commission (the “SEC”). The foregoing description of the Purchase Agreement and the Transaction contemplated thereby does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Purchase Agreement, a copy of which was filed with the SEC as Exhibit 2.1 to the September Form 8-K, and is incorporated herein by reference.

 

Item 2.03. Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.

 

The information set forth in Items 1.01 and 2.01 of this Current Report on Form 8-K are incorporated herein by reference.

 

Item 7.01. Regulation FD Disclosure.

 

On February 3, 2025, the Company announced the closing of the Transaction. A copy of the press release is furnished as Exhibit 99.1 and incorporated by reference herein.

 

The information in Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for purposes of Section 18 of Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended.

 

Item 9.01. Financial Statements and Exhibits.

 

(a) Financial statements of businesses or funds acquired.

 

The Company intends to file the financial statements required by Item 9.01(a) by amendment to this Current Report on Form 8-K not later than 71 calendar days after the date that this Current Report on Form 8-K is required to be filed with respect to the closing of the Transaction.

 

(b) Pro forma financial information.

 

The Company intends to file the pro forma financial information relating to the Transaction required by Item 9.01(b) by amendment to this Current Report on Form 8-K not later than 71 calendar days after the date that this Current Report on Form 8-K is required to be filed with respect to the closing of the Transaction.

 

 

 

 

(d) Exhibits.

 

Exhibit 
No.
  Description
2.1*   Asset Purchase Agreement, dated as of September 10, 2024, by and among the Company, Buyers, and Seller (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the SEC on September 12, 2024).
10.1*   Credit Agreement, dated as of January 31, 2025, by and between the Net-Zero North HoldCo, LLC, OIC Investment Agent, LLC, as administrative agent for the Lenders, and the other parties thereto.
10.2   Form of Term Loan Note
99.1   Press Release, dated February 3, 2025
104   Cover Page Interactive Data File (embedded as Inline XBRL document)

 

  * Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon its request.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  GEVO, INC.
     
Dated: February 3, 2025 By: /s/ E. Cabell Massey
    E. Cabell Massey
    Vice President, Legal and Corporate Secretary

 

 

 

Get the next $GEVO alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$GEVO

DatePrice TargetRatingAnalyst
8/21/2023$2.00Market Perform
Northland Capital
12/14/2022$2.25Neutral
UBS
10/19/2022$2.29Hold
Jefferies
2/9/2022$5.00Buy
Citigroup
8/24/2021$10.00Buy
Stifel
More analyst ratings

$GEVO
Press Releases

Fastest customizable press release news feed in the world

See more
  • Verity Announces Agreement with Minnesota Soybean Processors to Track and Verify Sustainable Agriculture Attributes

    ENGLEWOOD, Colo., April 03, 2025 (GLOBE NEWSWIRE) -- Verity Holdings, LLC ("Verity"), is pleased to announce we have partnered with Minnesota Soybean Processors ("MnSP") to implement Verity's proprietary track and trace software. This collaboration aims to unlock additional value for MnSP through export premiums while streamlining compliance reporting and auditability. "This partnership with MnSP is a great example of how Verity's technology empowers producers to capture and communicate the value of sustainable agriculture," said Kimberly Bowron, President of Verity. "By leveraging our advanced data verification and supply chain transparency solutions, MnSP can document key attributes w

    $GEVO
    Major Chemicals
    Industrials
  • Gevo to Participate in Virtual Investor Meeting

    ENGLEWOOD, Colo, March 31, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading developer of cost effective, renewable hydrocarbon fuels and chemicals with reduced greenhouse gas emissions, announced today that Eric Frey, Gevo's Vice President of Corporate Development, will participate in a Renmark Virtual Non-Deal Roadshow Series on Tuesday, April 1st at 10:00am ET.  Investors and other persons interested in participating in the event must register using the link below. Registration Link: https://www.renmarkfinancial.com/live-registration/renmark-virtual-non-deal-roadshow-nasdaq-gevo-yVFS8U3kU- About Gevo Gevo is a next-generation d

    $GEVO
    Major Chemicals
    Industrials
  • Gevo Reports Fourth Quarter 2024 Financial Results and Reaffirms Business Update

    ENGLEWOOD, Colo., March 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading developer of cost effective, renewable hydrocarbon fuels and chemicals with reduced greenhouse gas emissions, today announced financial results for the fourth quarter and full year ended December 31, 2024, and reaffirmed the Business Update that was released on March 7, 2025 (the "Business Update"), which is available on our website at https://investors.gevo.com/news-releases/news-release-details/gevo-provides-business-update-1. 2024 Fourth Quarter Financial Highlights Ended the fourth quarter with cash, cash equ

    $GEVO
    Major Chemicals
    Industrials

$GEVO
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$GEVO
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$GEVO
SEC Filings

See more

$GEVO
Leadership Updates

Live Leadership Updates

See more
  • Gevo Announces Appointment of Katie Ellet to Board of Directors

    ENGLEWOOD, Colo., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) is pleased to announce that Katie Ellet has been appointed to its board of directors as of January 2, 2024. Ms. Ellet serves as president, Hydrogen Energy and Mobility for North America at Air Liquide, a world leader in gases, technologies and services for Industry and Health, and a global innovator in low carbon hydrogen production. She has held a wide variety of leadership roles in the chemical and energy fields for the last 27 years. "We are honored to have Katie join our Board of Directors," said Dr. Patrick Gruber, CEO of Gevo. "She has a demonstrated record of technology expertise, market knowledge, and inn

    $GEVO
    Major Chemicals
    Industrials
  • Gevo Announces Appointment of Angelo Amorelli to Board of Directors

    ENGLEWOOD, Colo., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) is pleased to announce that Angelo Amorelli, PhD, has been appointed to its Board of Directors. Dr. Amorelli retired recently from bp, where he held leadership, development, and innovation roles for 35 years. "We are honored to have Angelo join our Board of Directors," said Dr. Patrick Gruber, CEO of Gevo. "We believe his innovation and technology experience at bp, specifically his efforts to champion bp's strategy around renewable energy and advanced biofuels, will provide significant benefit to Gevo's growth, including our billion-gallon sustainable aviation fuel production goal and our growing renewable natura

    $GEVO
    Major Chemicals
    Industrials
  • Gevo Announces Appointment of Carol Battershell to Board of Directors

    ENGLEWOOD, Colo., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) is pleased to announce that Carol J. Battershell has been appointed to its Board of Directors. Ms. Battershell is a seasoned executive with nearly 40 years in the energy sector in the United States and internationally. Carol is currently the Chief Executive Officer at Battersea Energy LLC, an energy consulting company and she previously served as Principal Deputy Director in the Office of Policy at the U.S. Department of Energy ("DOE"). "We are excited to have Carol join our Board of Directors," said Dr. Patrick Gruber, CEO of Gevo. "Her industry expertise and Department of Energy experience will be an invaluable

    $GEVO
    Major Chemicals
    Industrials

$GEVO
Financials

Live finance-specific insights

See more
  • Gevo Reports Fourth Quarter 2024 Financial Results and Reaffirms Business Update

    ENGLEWOOD, Colo., March 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading developer of cost effective, renewable hydrocarbon fuels and chemicals with reduced greenhouse gas emissions, today announced financial results for the fourth quarter and full year ended December 31, 2024, and reaffirmed the Business Update that was released on March 7, 2025 (the "Business Update"), which is available on our website at https://investors.gevo.com/news-releases/news-release-details/gevo-provides-business-update-1. 2024 Fourth Quarter Financial Highlights Ended the fourth quarter with cash, cash equ

    $GEVO
    Major Chemicals
    Industrials
  • Gevo Announces Rescheduled Fourth Quarter 2024 Earnings Release and Conference Call

    ENGLEWOOD, Colo., March 25, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) announced today that it will host its rescheduled conference call on March 27, 2025, at 4:30 p.m. ET (2:30 p.m. MT) to report its financial results for the fourth quarter ended December 31, 2024. To participate in the live call, please register through the following event weblink:   https://register.vevent.com/register/BIfe02700a31384d12946e60bf35964cb8  After registering, participants will be provided with a dial-in number and pin. To listen to the conference call (audio only), please register through the following event weblink:   https://edge.media-server.com/mmc/p/h9wkbjf5  A webcast replay will b

    $GEVO
    Major Chemicals
    Industrials
  • Gevo to Delay Issuance of Fourth Quarter and Full Year 2024 Earnings Release and Investor Conference Call

    ENGLEWOOD, Colo., March 06, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading developer of cost effective, renewable hydrocarbon fuels and chemicals with reduced greenhouse gas emissions, today announced that it will delay the issuance of its fourth quarter and full year 2024 earnings release and investor conference call previously scheduled for March 6, 2025. The delay in the earnings release is required to allow additional time to finalize certain accounting treatments related to our purchase of the assets of Red Trail Energy, LLC, and the capitalization of certain other project expenses. The Company will issue a separate press re

    $GEVO
    Major Chemicals
    Industrials

$GEVO
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more